CLINICAL_TRIALS
trial_result
· 2017-05-19
Clinical Trial Update: HEROIC (Heparin Requirement in Counterpulsation) [Phase 2]
Summary
Phase 2 HEROIC trial evaluating heparin requirements during counterpulsation in cardiogenic shock was terminated; results were posted May 19, 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Corewell Health East | Conditions: Cardiogenic Shock | Phase 2 | Status: TERMINATED | Results posted: 2017-05-19